Patients can also take an active role
The risk of yo-yo effects, where patients lose muscle on the drug and regain fat after stopping, is a real concern
The study period fell in the middle of the COVID-19 pandemic, where there was a minimum 6-month delay between presenting in primary care, receiving an evaluation and referral to secondary care
Ipamorelin showed dose-proportional pharmacokinetics with a terminal half-life of about 2 hours and a single discrete GH pulse peaking near 0.67 h in healthy human volunteers (Gobburu et al., Pharmaceutical Research, 1999)
Its also important to note that semaglutide did not eliminate alcohol use or stop drinking entirely
For 48 hours following your treatment, refrain from heavy activity